MedPath

A Study of Vyaghryadi Churna (Powder) in the treatment of Tamaka Shwasa (Bronchial Asthma)

Phase 2
Conditions
Health Condition 1: J459- Other and unspecified asthma
Registration Number
CTRI/2021/11/037958
Lead Sponsor
DR NILAM MAHADEV SAMBRE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)CHILDREN WITH SYMPTOMS OF TAMAKA SHWASA AS MENTIONED BY CHARAK ARE AS FOLLOWS

SHWASAKRUCHHRATA(DYSPNEA)

KASA(COUGH)

GHUR GHUR SHABDA(WHEEZING)

KASHTEN SHLESHMA MOKSHA(DIFFICULTY IN EXPECTORANT)

PEENAS

2)CHILDREN ARE OF AGE GROUP 1YEAR TO 12 YEARS

3)CHILDREN WHO HAVE A HISTORY OF URTI 3-4 TIMES PER YEAR AND ALLERGIC RHINITIS AND ALSO HISTORY OF USING NEBULIZATION FREQUENTLY

4)CHILDREN WILL BE SELECTED IRRESPECTIVE OF SEX SOCIO ECONOMIC STATUS

5)CHILDRENS WHOSE PARENTS ARE READY TO PARTICIPATE IN THE CLINICAL TRIAL BY GIVING INFORM WRITTEN CONSENT

Exclusion Criteria

1)PATIENTS HAVING LIFE THREATENING ILLNESS AND WHO ARE BED RIDDEN

2)PATIENTS HAVING ANY CONGEITAL RESPIRATORY AND GIT ABNORMALITY

3)PATIENTS WHO REQUIRE SURGICAL MANAGEMENT

4)PATIENTS WITH THE HISTORY OF PULMONARY TUBERCULOSIS PLEURAL EFFUSION EMPHYSEMA BRONCHIAL CARCINOMA STATUS ASTHMATICUS

5)PATIENTS HAVING OTHER SYSTEMIC MAJOR ILLNESS SUCH AS AIDS CARDIAC DISEASE RENAL FAILURE

6)PATIENTS WITH SEVERE ASTHMATICUS CONDITION WHO NEEDS EMERGENCY TREATMENT

7)PATIENTS HAVING DISEASE COVID19 TUBERCULOSIS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath